Tom Reeve Academic Surgical Clinic · St Leonards
Conditions · Gallbladder cancer
Gallbladder cancer is uncommon but is the most prevalent malignancy of the biliary tract worldwide. Professor Tom Hugh provides specialist hepatobiliary assessment in St Leonards, with surgery at Royal North Shore Hospital and North Shore Private Hospital when appropriate.
<3 /100k
Typical incidence in many populations
Gallstones
A major recognised risk factor
Resection
Only curative treatment when feasible
MDT
Complex cases discussed in cancer teams
Page last reviewed July 2026. Figures below summarise published epidemiology and symptom ranges used in specialist practice summaries.
Main risk factors include:
Overall five-year survival for advanced disease is reported as less than 5% in published summaries. Radical resection remains the only curative treatment when it is feasible.
Postoperative chemotherapy is commonly used. When the cancer cannot be removed, bile drainage may be restored with a stent through the narrowed duct, and palliative chemotherapy may be offered. Care is coordinated through multidisciplinary teams listed on Professor Hugh’s about page.
It is relatively uncommon overall, with estimated incidence under 3 per 100,000 in many populations, but rates vary by geography, ethnicity and sex. It is the most prevalent malignancy of the biliary tract worldwide.
Early symptoms are non-specific and can resemble biliary colic or cholecystitis. Some cancers are found incidentally after cholecystectomy for presumed benign disease. Advanced disease at diagnosis is associated with a poorer prognosis.
Radical resection of the gallbladder (and appropriate adjacent tissue when indicated) is the only curative treatment. Other options are limited when the tumour cannot be removed.
Cholangiocarcinoma can arise outside the liver, at the liver hilum (Klatskin tumour), or within the liver. Treatment may involve duct excision with lymph nodes, liver resection, stenting for drainage, and chemotherapy depending on location and stage.
External authority: Gallbladder cancer information, Cancer Institute NSW.